Abstract | BACKGROUND: MATERIALS AND METHODS: RESULTS: The cytotoxicity and antitumor effect of EGF- PMBN-PTX were significantly greater than those of PMBN-PTX for EGFR-overexpressing cells but not for an EGFR-deficient line. CONCLUSION: These results suggest that EGF- PMBN-PTX may represent a more potent targeted therapy for tumors overexpressing EGFR.
|
Authors | Toshiyuki Shimada, Masakazu Ueda, Hiromitsu Jinno, Naokazu Chiba, Masahiro Wada, Junji Watanabe, Kazuhiko Ishihara, Yuko Kitagawa |
Journal | Anticancer research
(Anticancer Res)
Vol. 29
Issue 4
Pg. 1009-14
(Apr 2009)
ISSN: 0250-7005 [Print] Greece |
PMID | 19414339
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents, Phytogenic
- Methacrylates
- Phosphorylcholine
- 2-methacryloyloxyethyl phosphorylcholine
- Epidermal Growth Factor
- ErbB Receptors
- Paclitaxel
|
Topics |
- Animals
- Antineoplastic Agents, Phytogenic
(administration & dosage, pharmacokinetics)
- Breast Neoplasms
(drug therapy, pathology)
- Drug Delivery Systems
- Epidermal Growth Factor
(chemistry)
- ErbB Receptors
(metabolism)
- Female
- Humans
- Infusions, Subcutaneous
- Methacrylates
(chemistry)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Nanoparticles
- Paclitaxel
(administration & dosage, pharmacokinetics)
- Phosphorylcholine
(analogs & derivatives, chemistry)
- Tissue Distribution
- Tumor Cells, Cultured
|